Depression - Dementia and Depression - Cost-Effectiveness of Mirtazapine and Sertraline

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2013年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of depression case management in small practices
    Gensichen, Jochen
    Petersen, Juliana J.
    Von Korff, Michael
    Heider, Dirk
    Baron, Steffen
    Koenig, Jochem
    Freytag, Antje
    Krauth, Christian
    Gerlach, Ferdinand M.
    Koenig, Hans-Helmut
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (06) : 441 - 446
  • [32] Model to assess the cost-effectiveness of new treatments for depression
    Sobocki, Patrik
    Ekman, Mattias
    Agren, Hans
    Jonsson, Bengt
    Rehnberg, Clas
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (04) : 469 - 477
  • [33] Cost-effectiveness of improved depression treatment in primary care
    Simon, GE
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2000, 30 (04): : 403 - 404
  • [34] The cost-effectiveness of depression screening for the general adult population
    Yildirim, Melike
    Gaynes, Bradley N.
    Keskinocak, Pinar
    Pence, Brian W.
    Swann, Julie
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 303 : 306 - 314
  • [35] Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial
    Henderson, Catherine
    Knapp, Martin
    Stirling, Susan
    Shepstone, Lee
    High, Juliet
    Ballard, Clive
    Bentham, Peter
    Burns, Alistair
    Farina, Nicolas
    Fox, Chris
    Fountain, Julia
    Francis, Paul
    Howard, Robert
    Leroi, Iracema
    Livingston, Gill
    Nilforooshan, Ramin
    Nurock, Shirley
    O'Brien, John T.
    Price, Annabel
    Swart, Ann Marie
    Tabet, Naji
    Telling, Tanya
    Thomas, Alan J.
    Banerjee, Sube
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (10) : 905 - 917
  • [36] Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
    Sirot, Jaquenoud E.
    Harenberg, S.
    Vandel, P.
    Mendonca Lima, C. A.
    Perrenoud, P.
    Kemmerling, K.
    Zullino, D. F.
    Hilleret, H.
    Crettol, S.
    Jonzier-Perey, M.
    Golay, Powell K.
    Brocard, M.
    Eap, C. B.
    Baumann, P.
    PHARMACOPSYCHIATRY, 2012, 45 (06) : 253 - 253
  • [37] Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression
    Katon, W
    Unützer, J
    Fan, MY
    Williams, JW
    Schoenbaum, M
    Lin, EHB
    Hunkeler, EM
    DIABETES CARE, 2006, 29 (02) : 265 - 270
  • [38] Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression
    Von Korff, M
    Katon, W
    Bush, T
    Lin, EHB
    Simon, GE
    Saunders, K
    Ludman, E
    Walker, E
    Unutzer, J
    PSYCHOSOMATIC MEDICINE, 1998, 60 (02): : 143 - 149
  • [39] Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial
    Zuidersma, Marij
    Chua, Kia-Chong
    Hellier, Jennifer
    Voshaar, Richard Oude
    Banerjee, Sube
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (09): : 920 - 931
  • [40] Cost-Effectiveness of the Treatment of Depression in Old Age A Systematic Review
    Bock, Jens-Oliver
    Brettschneider, Christian
    Wegener, Annemarie
    Riedel-Heller, Steffi
    Koenig, Hans-Helmut
    PSYCHIATRISCHE PRAXIS, 2015, 42 (05) : 240 - 247
12345